Vaccine Marketing - Innovation and Marketing in the Pharmaceutical Industry - page 413

Maurer J, Uscher-Pines L, Harris KM (2010a) Perceived seriousness of seasonal and A(H1N1)
infl uenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source
of information matter? Prev Med 51(2):185-187
Maurer J, Uscher-Pines L, Harris KM (2010b) Awareness of government seasonal and 2009
H1N1 infl uenza vaccination recommendations among targeted US adults: the role of provider
interactions. Am J Infect Control 38(6):489-490
McNeil DG Jr (2011) For fi rst time, UNICEF reveals differences in prices it pays drug companies
for vaccines. New York Times, 27 May
Miller BL, Kretsinger K, Euler GL, Lu P, Ahmed F (2011) Barriers to early uptake of tetanus,
diphtheria and acellular pertussis vaccine (tdap) among adults—United States, 2005-2007.
Vaccine 29(22):3850-3856
Millstein SG (1996) Utility of the theories of reasoned action and planned behavior for predicting
physician behavior: a prospective analysis. Health Psychol 15(5):398-402
Milstien JB, Kaddar M (2010) The role of emerging manufacturers in access to innovative vaccines
of public health importance. Vaccine 28(9):2115-2121
Milstien J, Cardenas V, Cheyne J, Brooks A (2010) WHO policy development processes for a new
vaccine: case study of malaria vaccines. Malar J 9:182
Moore GR, Crosby RA, Young A, Charnigo R (2010) Low rates of free human papillomavirus
vaccine uptake among young women. Sex Health 7(3):287-290
Morgon PA (2011) Opening doors to the developing world through superior market access strate-
gies. Investor Day, Mar
Morison LA, Cozzolino PJ, Orbell S (2010) Temporal perspective and parental intention to accept
the human papillomavirus vaccination for their daughter. Br J Health Psychol 15(Pt 1):
151-165
Moxon ER, Siegrist C (2011) The next decade of vaccines: societal and scientifi c challenges.
Lancet 378(9788):348-359
Myers LB, Goodwin R (2011) Determinants of adults' intention to vaccinate against pandemic
swine fl u. BMC Public Health 11(1):15
National Center for Health Statistics (2011) Health, United States, 2010: with special feature on
death and dying. National Center for Health Statistics, Hyattsville, MD
Nguyen A, Furrer E, Schwalbe N (2011) Market shaping: strategic considerations for a healthy
vaccine marketplace. The GAVI Alliance. http://www.gavialliance.org/library/gavi- documents/
white-papers/ . Accessed 24 Aug 2011
Nicholson MS, Leask J (2012) Lessons from an online debate about measles-mumps-rubella
(MMR) immunization. Vaccine 30(25):3806-3812
Nolan TM (2010) The Australian model of immunization advice and vaccine funding. Vaccine
28(Suppl 1):A76-A83
Nordquist G, Wu S (1976) The joint demand for health insurance and preventive medicine. In: Rosett
RN (ed) The role of health insurance in the health services sector. National Bureau of Economic
Research, New York, NY
O f fi t AP (2011) Deadly choices: how the anti-vaccine movement threatens us all. Basic topics,
New York, NY
Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N (2009) Vaccine refusal, mandatory
immunization, and the risks of vaccine-preventable diseases. N Engl J Med 360(19):
1981-1988
Orenstein WA, Mootrey GT, Pazol K, Hinman AR (2007) Financing immunization of adults in the
United States. Clin Pharmacol Ther 82(6):764-768
Palli S, Mehta S, Chatterjee S, Aparasu R (2010) Prevalence and correlates of human papillomavi-
rus vaccination in adolescent girls: results from a national survey of children's health. Value
Health 13(3):A47
Pan American Health Organization (2010) The revolving fund as a cooperation mechanism for
immunization programs in the Americas—FAQs. http://new.paho.org/hq/dmdocuments/2010/
RevolvingFund_FAQs_ENG.pdf . Accessed 22 Aug 2011